Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Acetate for Wilson's Disease in Japan
NCT00212368Phase 3Completed
- Sponsor
- Nobelpharma Co., Ltd.
- Start
- Oct 2004
- Primary completion
- Aug 2005
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of zinc acetate in Wilson's disease, sponsored by Nobelpharma Co., Ltd. Primary endpoint: Urinary copper excretion. Started Oct 2004; status: completed.
02
Drugs
zinc acetate
03
Conditions
Wilson's disease
Beyond the preview
Go deeper on NCT00212368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00212368.